Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A4782 Ammonium iron(III) citrateSummary: A compound that induces ferroptosis and promotes protein production -
A4785 Musk ketoneSummary: A flavoring agent with neuroprotective effects that promotes stem cell proliferation and differentiation -
A4786 BiP inducer XSummary: A GRP78 inducer that selectively induces BiP expression for ER stress and neurodegenerative disease -
A4789 Methyl 3,4-dihydroxybenzoateSummary: A tea polyphenol metabolite derivative with antioxidant and anti-inflammatory activities -
A4790 TBHQSummary: An organic phenolic compound that activates the Nrf2 and ERK pathways -
A4792 Hematoporphyrin dihydrochlorideSummary: A photosensitizer and affinity chromatography substrate for tumors -
A4799 GPNA hydrochlorideSummary: An inhibitor that specifically inhibits the glutamine transporter ASCT2 and induces apoptosis -
A8965 VTP50469Summary: A highly selective, orally bioavailable Menin-MLL interaction inhibitor -
A8972 AvitinibSummary: A tyrosine kinase inhibitor targeting EGFR and BTK for antitumor therapy -
A4749 18α-Glycyrrhetinic acidSummary: A compound that inhibits NF-κB, activates the proteasome and induces apoptosis


